Insulin-like growth factor 1 inhibits autophagy of human colorectal carcinoma drug-resistant cells via the protein kinase B/mammalian target of rapamycin signaling pathway

由 Wang, Shuomin, Gu, Kangsheng
發表在 Mol Med Rep (2018)

MicroRNA-200c as a prognostic and sensitivity marker for platinum chemotherapy in advanced gastric cancer

由 Li, Min, Gu, Kangsheng, Liu, Wei, Xie, Xiaoque, Huang, Xiaolu
發表在 Oncotarget (2017)

Oxaliplatin-Based Regimen is Superior to Cisplatin-Based Regimen in Tumour Remission as First-line Chemotherapy for Advanced Gastric Cancer: A Meta-Analysis

由 Zhang, Fei, Zhang, Yiyin, Jia, Zhenya, Wu, Hongyang, Gu, Kangsheng
發表在 J Cancer (2019)

Thalidomide plus chemotherapy exhibit enhanced efficacy in the clinical treatment of T-cell non-Hodgkin’s lymphoma: A prospective study of 46 cases

由 WU, HONGYANG, ZHAO, CHENCHEN, GU, KANGSHENG, JIAO, YANG, HAO, JIQING, SUN, GUOPING
出版 2014

Downregulation of SPARC Expression Decreases Cell Migration and Invasion Involving Epithelial-Mesenchymal Transition through the p-FAK/p-ERK Pathway in Esophageal Squamous Cell Car...

由 Zhang, Fei, Zhang, Yiyin, Da, Jie, Jia, Zhenya, Wu, Hongyang, Gu, Kangsheng
發表在 J Cancer (2020)

MicroRNA-200c reverses drug resistance of human gastric cancer cells by targeting regulation of the NER-ERCC3/4 pathway

由 Li, Min, Gao, Min, Xie, Xiaoque, Zhang, Yiyin, Ning, Jie, Liu, Pingping, Gu, Kangsheng
發表在 Oncol Lett (2019)

Diagnostic, clinicopathologic, therapeutic and prognostic value of Plasma Heat Shock Protein 90 levels in patients with advanced Gastrointestinal Carcinoma

由 Zhang, Yiyin, Ni, Longgang, Li, Qianqian, Li, Min, Zhu, Jiejie, Zhang, Fei, Gu, Kangsheng
發表在 J Cancer (2020)

Intravenous flurbiprofen axetil can increase analgesic effect in refractory cancer pain

由 Wu, Hongyang, Chen, Zhendong, Sun, Guoping, Gu, Kangsheng, Pan, Yueyin, Hao, Jiqing, Du, Yingying, Ning, Jie
出版 2009

Prognostic Value of the Expression of DNA Repair–Related Biomarkers Mediated by Alcohol in Gastric Cancer Patients

由 Zhang, Yiyin, Wu, Hongyang, Yang, Feng, Ning, Jie, Li, Min, Zhao, Chenchen, Zhong, Shuping, Gu, Kangsheng, Wang, Hua
發表在 Am J Pathol (2018)

Survival analysis of patients with advanced non‐small cell lung cancer receiving tyrosine kinase inhibitor (TKI) treatment: A multi‐center retrospective study

由 Shi, Qingming, Guan, Maojing, Wang, Yong, Xu, Congjing, Tang, Lei, Fu, Wenhua, Bi, Minghong, Sun, Xiang, Gu, Kangsheng, Pang, Dongsheng
發表在 Thorac Cancer (2017)

MicroRNA-362-5p enhances the cisplatin sensitivity of gastric cancer cells by targeting suppressor of zeste 12 protein

由 Wei, Xiaoli, Gao, Mengru, Ahmed, Yaser, Gao, Min, Liu, Wenbo, Zhang, Yiyin, Xie, Xiaoque, Zhao, Qihong, Wang, Hua, Gu, Kangsheng
發表在 Oncol Lett (2019)

MiR-192-5p reverses cisplatin resistance by targeting ERCC3 and ERCC4 in SGC7901/DDP cells

由 Xie, Xiaoque, Huang, Nana, Zhang, Yiyin, Wei, Xiaoli, Gao, Mengru, Li, Min, Ning, Jie, Liu, Wei, Zhao, Qihong, Wang, Hua, Gu, Kangsheng
發表在 J Cancer (2019)

Diagnostic, Therapeutic Predictive, and Prognostic Value of Neutrophil Extracellular Traps in Patients With Gastric Adenocarcinoma

由 Zhang, Yiyin, Hu, Yangyang, Ma, Cui, Sun, Hua, Wei, Xiaoli, Li, Min, Wei, Wei, Zhang, Fei, Yang, Feng, Wang, Hua, Gu, Kangsheng
發表在 Front Oncol (2020)

Fulvestrant 500 mg vs 250 mg in postmenopausal women with estrogen receptor-positive advanced breast cancer: a randomized, double-blind registrational trial in China

由 Zhang, Qingyuan, Shao, Zhimin, Shen, Kunwei, Li, Li, Feng, Jifeng, Tong, Zhongsheng, Gu, Kangsheng, Wang, Xiaojia, Xu, Binghe, Sun, Guofang, Chen, Huifang, Rukazenkov, Yuri, Jiang, Zefei
發表在 Oncotarget (2016)

Prognostic value of DNA aneuploidy in gastric cancer: a meta-analysis of 3449 cases

由 Xu, Jing, Zhu, Ruolin, Fan, Lulu, Ge, Shangqing, Wei, Wei, Li, Xiaoqiu, Da, Liangshan, Jia, Zhenya, Zhao, Zhiyan, Ning, Jie, Da, Jie, Peng, Wanren, Gu, Kangsheng, Sun, Guoping
發表在 BMC Cancer (2019)

A Phase II, Randomized, Double-blind, Placebo-controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma

由 Cui, Chuanliang, Mao, Lili, Chi, Zhihong, Si, Lu, Sheng, Xinan, Kong, Yan, Li, Siming, Lian, Bin, Gu, Kangsheng, Tao, Min, Song, Xin, Lin, Tongyu, Ren, Xiubao, Qin, Shukui, Guo, Jun
出版 2013

A proposal for a new staging system for extranodal natural killer T-cell lymphoma: a multicenter study from China and Asia Lymphoma Study Group

由 Hong, Huangming, Li, Yexiong, Lim, Soon Thye, Liang, Chaoyong, Huang, He, Yi, Pingyong, Wu, Tao, Du, Xin, Zhang, Mingzhi, Wang, Jinghua, Zhu, Jun, Liu, Ting, Meng, Fanyi, Wu, Gang, Guo, Ye, Zhu, Yuan, Zhao, Weili, Jin, Jie, Li, Juan, Deng, Yanming, Gu, Kangsheng, Wu, Xiangyuan, Ke, Xiaoyan, Xie, Derong, Lin, Daren, Peng, Zhigang, Wu, Junxin, Liu, Qing, Kim, Won Seog, Lin, Tongyu
發表在 Leukemia (2020)

Chinese Guidelines on the Diagnosis and Treatment of Melanoma (2015 Edition)

由 Guo, Jun, Qin, Shukui, Liang, Jun, Lin, Tongyu, Si, Lu, Chen, Xiaohong, Chi, Zhihong, Cui, Chuanliang, Du, Nan, Fan, Yun, Gu, Kangsheng, Li, Fang, Li, Junling, Li, Yongheng, Liang, Houjie, Liu, Jiwei, Lu, Man, Lu, Aiping, Nan, Kejun, Niu, Xiaohui, Pan, Hongming, Ren, Guoxin, Ren, Xiubao, Shu, Yongqian, Song, Xin, Tao, Min, Wang, Baocheng, Wei, Wenbin, Wu, Di, Wu, Lingying, Wu, Aiwen, Xu, Xiaolin, Zhang, Junyi, Zhang, Xiaoshi, Zhang, Yiping, Zhu, Huiyan
發表在 Ann Transl Med (2015)

Utilization of circulating cell-free DNA profiling to guide first-line chemotherapy in advanced lung squamous cell carcinoma

由 Jiang, Tao, Jiang, Liyan, Dong, Xiaorong, Gu, Kangsheng, Pan, Yueyin, Shi, Qin, Zhang, Guojun, Wang, Huijuan, Zhang, Xiaochun, Yang, Nong, Li, Yuping, Xiong, Jianping, Yi, Tienan, Peng, Min, Song, Yong, Fan, Yun, Cui, Jiuwei, Chen, Gongyan, Tan, Wei, Zang, Aimin, Guo, Qisen, Zhao, Guangqiang, Wang, Ziping, He, Jianxing, Yao, Wenxiu, Wu, Xiaohong, Chen, Kai, Hu, Xiaohua, Hu, Chunhong, Yue, Lu, Jiang, Da, Wang, Guangfa, Liu, Junfeng, Yu, Guohua, Li, Junling, Zhang, Henghui, Wu, Lihong, Fang, Lu, Liang, Dandan, Zhao, Yi, Zhao, Weihong, Xie, Wenmin, Ren, Shengxiang, Zhou, Caicun
發表在 Theranostics (2021)